US fibrosis-focused drug developer Mediar Therapeutics has entered into global licensing agreement with US pharma major Eli ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease characterized by progressive scarring of lung ...

Research highlights gender-based disparities in lung transplantation, showing women face longer wait times yet achieve better ...

Nuformix plc (LON:NFX – Get Free Report)’s share price traded down 18.5% during trading on Monday . The company traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.05 ($0.00). 45,228,297 shares ...

Mediar Therapeutics has entered a global licensing agreement with Eli Lilly and Company to progress the human immunoglobulin ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their ...

Brodie Lee passed away from idiopathic pulmonary fibrosis on December 26, 2020. He was a former one-time AEW TNT Champion. He was also famous for his stint in WWE under the ring name Luke Harper where ...

Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), formerly known as Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a ...